Brief: Cipla Says U.S. Unit To Initiate Recall Of Lanreotide Injection
09/03/2026 20:33
March 9 (Reuters) - Cipla Ltd CIPL.NS: U.S. UNIT TO INITIATE RECALL OF LANREOTIDE INJECTION, TEMPORARY SUPPLY SHORTAGE EXPECTED Source text: ID:nNSE7dfw5l Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate